Eneda Toska
Johns Hopkins University(US)University of Baltimore(US)
Publications by Year
Research Areas
RNA modifications and cancer, RNA Research and Splicing, Epigenetics and DNA Methylation, Immune cells in cancer, Polyamine Metabolism and Applications
Most-Cited Works
- → PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer(2023)1,721 cited
- → PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer(2015)434 cited
- → Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors(2019)286 cited
- → PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D(2017)264 cited
- → ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer(2020)230 cited
- → PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition(2016)225 cited
- → Resistance to TRK inhibition mediated by convergent MAPK pathway activation(2019)221 cited
- → The present and future of PI3K inhibitors for cancer therapy(2021)213 cited
- → Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma(2020)156 cited
- → Overview of the relevance of PI3K pathway in HR-positive breast cancer(2019)155 cited